Recent posts

TypePostAuthorRepliesLast updated
Blog entryTDR and the Pooled Fund for R&D: WHO demonstration projects and CEWG follow-up thiru017 hours 50 min ago
PageThe Big Idea: Prizes to Stimulate R&D for New Medicines thiru02 days 8 hours ago
Book pageJames Love, Director James Love02 days 9 hours ago
Blog entryOMB's Revised Guidance on Appointment of Lobbyists to Federal Advisory Committees, Boards, and Commissions James Love03 days 12 hours ago
Book pageCPTech's 2003 reports for the RSA Competition Commission, in Hazel Tau et al.v GSK, Boehringer, et al KEI Staff05 days 17 hours ago
PageThe USTR Special 301 Reports, 1989 to 2014 James Love06 days 12 hours ago
Blog entryGilead's US patient access programs for Sovaldi Elizabeth Rajasingh01 week 1 day ago
Blog entryWIPO General Assembly 2014: Hard Decisions on the Design Law Treaty and Treaty for Protection of Genetic Resources thiru01 week 5 days ago
Blog entrySome recent cancer drug prices James Love02 weeks 5 hours ago
Blog entryMoney speaks: USTR releases letters from Congress backing PhRMA on exclusive rights biologic test data in TPP KEI Staff02 weeks 1 day ago
Blog entryUS proposal: IGC Work Plan for 2015-Is the IGC train leaving the station? thiru02 weeks 1 day ago
Blog entryGilead's MPP license for tenofovir alafenamide (TAF) patents James Love02 weeks 4 days ago
PageElizabeth Rajasingh, Perls Fellow Elizabeth Rajasingh02 weeks 5 days ago
Book pageHepatitis C Claire Cassedy02 weeks 5 days ago
StoryTimeline of privileges regarding the commercialization and use of knowledge. Part 2: 1980 to 1999 KEI Staff02 weeks 5 days ago
Blog entryHepatitis research and development timeline James Love03 weeks 16 hours ago
PageAbbott sought compulsory license in 2007 US patent dispute thiru03 weeks 1 day ago
Book pageHepatitis James Love03 weeks 1 day ago
StoryTimelines James Love03 weeks 2 days ago
Blog entry KEI asks FTC to investigate Shire decision to abandon efforts to compete in US market for Fabry’s disease treatments James Love03 weeks 4 days ago
Blog entry Hepatitis C Virus patent assignments: patents with HCV in the patent claim James Love03 weeks 6 days ago
Blog entryNew UK Parliamentary report on Global TB urges the United Kingdom to explore a WTO Agreement on the Provision of Public Goods thiru04 weeks 1 day ago
Blog entryKEI Policy Brief: Non-Voluntary use of HCV patents in the United States James Love04 weeks 4 days ago
Blog entrySCCR28: Chair’s Conclusions (No recommendations on broadcasting or limitations and exceptions for libraries and archives) thiru04 weeks 4 days ago
Blog entryGilead in 2013: AbbVie sought to eliminate competition and dominate market for HCV drugs James Love04 weeks 6 days ago